| US12043622B2 | 23 July 2024 | Grant | US17254097 | Crystal form of compound for inhibiting the activity of cdk4/6 and use thereof | Betta Pharmaceuticals Co Ltd |
|---|
| US11845762B2 | 19 December 2023 | Grant | US17898258 | Compound functioning as bromodomain protein inhibitor, and composition | Betta Pharmaceuticals Co Ltd |
|---|
| US11466034B2 | 11 October 2022 | Grant | US16954901 | Compound functioning as bromodomain protein inhibitor, and composition | Betta Pharmaceuticals Co Ltd |
|---|
| US11466013B2 | 11 October 2022 | Grant | US16973335 | Erk inhibitor and use thereof | Betta Pharmaceuticals Co Ltd |
|---|
| US11365196B2 | 21 June 2022 | Grant | US16488899 | Fgfr inhibitor and application thereof | Betta Pharmaceuticals Co Ltd |
|---|